HOME >> BIOLOGY >> NEWS
American Institute of Chemists names Ralph Hirschmann AIC Gold Medalist

PHILADELPHIA 11 April 2003 The American Institute of Chemists (AIC) and the Chemical Heritage Foundation (CHF) will present the 2003 AIC Gold Medal to Ralph F. Hirschmann. The award ceremony will be part of Heritage Day festivities at CHF in Philadelphia, Pennsylvania, on Thursday, 12 June 2003.

It is fitting that the first AIC Gold Medal awarded jointly by CHF and the AIC be presented to a pharmaceutical researcher with the talent, skills, and insight of Ralph Hirschmann, said Arnold Thackray, president of CHF. At Merck, he was head of the effort that developed effective drugs to treat hypertension, congestive heart failure, severe infection, river blindness in developing countries, and many other illnesses. His remarkable accomplishments as a researcher include the synthesis of the enzyme ribonuclease in solution, the first example of protein synthesis.

The presentation of the AIC Gold Medal will be part of a day devoted to celebrating the achievement and promise of the chemical and molecular sciences. Heritage Day begins with the awarding of the Othmer Gold Medal to John D. Baldeschwieler and George S. Hammond. In the late afternoon, Hirschmann will receive the AIC Gold Medal. Following a reception, the Winthrop-Sears Medal of The Chemists Club will be presented at a dinner at nearby Carpenters Hall.

Ralph F. Hirschmann
Ralph F. Hirschmann is Makineni Professor of Bioorganic Chemistry at the University of Pennsylvania. He joined the Penn faculty in 1987 after retiring as Mercks senior vice president of basic research. He was affiliated with Merck for 37 years, during which time he fostered interdisciplinary research as well as collaborations between academia and industry, practices he has continued at Penn.

Several widely used medications stem from Hirschmanns tenure at Merck, including the parasite-fighting Ivomec. And, in a major theoretical contribution to organic chemistry, he was the first to discover that chem
'"/>

Contact: Neil Gussman
neilg@chemheritage.org
717-314-2494
Chemical Heritage Foundation
16-Apr-2003


Page: 1 2

Related biology news :

1. Highlights of the October 2004 Journal of the American Dietetic Association
2. The American Phytopathological Society announces 2004 awards
3. Tips from the Journals of the American Society for Microbiology
4. Highlights of American Chemical Society national meeting in Philadelphia, Aug. 22-26
5. NIH roadmap for biomedical research focus of chemists at American Chemical Society meeting
6. Tips from the journals of the American Society for Microbiology
7. Genetic mutation linked to more aggressive breast cancer found more often in African-Americans
8. More aggressive breast cancer tumors found in African American women
9. American Society of Mammalogists honors CI president Russell Mittermeier with Aldo Leopold award
10. Tips from the Journals of the American Society for Microbiology
11. Most Americans not sure about the sources of high cholesterol

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/1/2020)... ... July 01, 2020 , ... Catalent, a global leader ... Teva-Takeda Pharmaceuticals’ packaging facility in Minakuchi, located in the Shiga prefecture of Japan. ... in Kakegawa, the new 60,000-square-foot facility will provide customers with flexible clinical supply ...
(Date:6/28/2020)... ... June 25, 2020 , ... In an upcoming episode scheduled for the ... of Care Testing solutions (POCT). Check local listings for more info. , Today, the ... and are shipped to labs throughout the country. Results are then available several days ...
(Date:6/23/2020)... ... June 23, 2020 , ... First Aid ... Ltd, a UK supplier and manufacturer of innovative portable renewable energy equipment, have ... the fight against the COVID-19 pandemic in Zambia. , One of Renovagen’s FAST ...
Breaking Biology News(10 mins):
(Date:6/23/2020)... (PRWEB) , ... June 22, 2020 , ... ... lead glutamine antagonist, DRP-104, will be presented June 22-24 during the American Association ... of DRP-104; and, the other profiles the potent, consistent single agent activity in ...
(Date:6/11/2020)... ... June 08, 2020 , ... Greffex, a leading genetic engineering ... proprietary clean viral vectors, recently announced a key manufacturing agreement with FUJIFILM Diosynth ... the world’s most successful gene therapy delivery vehicle (vector) with broad applications for ...
(Date:6/11/2020)... HOUSTON (PRWEB) , ... June 09, 2020 , ... Reducing ... around the world. From the Paris Agreement to stock market dips, ways to reduce ... are adding biofuels to their portfolio. Most of the biofuels being produced today are ...
(Date:5/30/2020)... ... 29, 2020 , ... Medrio, Inc., the leading provider of ... enabled Cytovale, Inc., a medical technology company dedicated to revolutionizing diagnostics for conditions ... patient in (FPI) in just seven days. The Cytovale technology will allow patients ...
Breaking Biology Technology:
Cached News: